Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

6.820 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.820
Bid (Size) 6.010 (1)
Ask (Size) 7.140 (1)
Prev. Close 6.820
Today's Range 6.820 - 6.820
52wk Range 4.950 - 14.84
Shares Outstanding 7,486,120
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
Applied DNA and A&E come together to bring an innovative and economical solution to brands to authenticate and validate their products. 
From Business Wire News Releases
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial La
Applied DNA veterinary COVID-19 vaccine induces NAbs against B.1.1.7, P1, and B.1.526 variants; Set launch of mink challenge trial for August. 
From Business Wire News Releases

Performance

YTD
+28.20%
+28.20%
1 Month
+18.61%
+18.61%
3 Month
-11.20%
-11.20%
6 Month
+23.33%
+23.33%
1 Year
-10.85%
-10.85%

More News

Read More
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing
From Business Wire News Releases
Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
From Business Wire News Releases
Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021
From Business Wire News Releases
Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues
From Business Wire News Releases
Applied DNA's Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies Against Three Variants
Tags APDN General COVID/19 Vaccine
From Benzinga
FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
From Business Wire News Releases
Analysts Predict 22% Gains Ahead For The Holdings of IWC
Tags ETFs
From ETF Channel
Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing
From Business Wire News Releases
Thinking about buying stock in Applied DNA Sciences, Sundial Growers, New Oriental Education, BlackBerry, or Evofem Biosciences?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.